The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
Similar stories
6 outlets
See how this story developed, hour by hour
This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results
finance.yahoo.com
19.08.2026
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
time.com
19.08.2026
BioNTech Stock Surges 22% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.
barrons.com
20.08.2026
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
marketwatch.com
19.08.2026
Moderna's Cancer Vaccine Could Change America in 7 Surprising Ways
newsweek.com
20.08.2026
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
aljazeera.com
19.08.2026
Related stories
Your 60/40 Portfolio May Be 100% Exposed to a Dying Dollar, Bitwise Says
Palantir Stock Could Be in for a Big September. Here’s Why.
Abercrombie & Fitch Soars 37% on a $100M Tariff Refund and Raised Guidance, Ross and Kohl’s Hold Steady
XRP Leads Crypto Pullback as Leverage Unwind Tests Rally
Every Insurer’s Medigap Plan G Covers the Same Benefits. The Premium Isn’t and on Most Policies It Climbs Every Birthday.
Why Abercrombie & Fitch Stock Is Having Its Best Day in 9 Months